229 related articles for article (PubMed ID: 24824039)
21. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
22. Withaferin A inhibits expression of ataxia telangiectasia and Rad3-related kinase and enhances sensitivity of human breast cancer cells to cisplatin.
Hahm ER; Lee J; Abella T; Singh SV
Mol Carcinog; 2019 Nov; 58(11):2139-2148. PubMed ID: 31441116
[TBL] [Abstract][Full Text] [Related]
23. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
[TBL] [Abstract][Full Text] [Related]
24. RNA-seq reveals novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells.
Hahm ER; Kim SH; Singh KB; Singh SV
Mol Carcinog; 2021 Jan; 60(1):3-14. PubMed ID: 33150660
[TBL] [Abstract][Full Text] [Related]
25. Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model.
Hahm ER; Lee J; Kim SH; Sehrawat A; Arlotti JA; Shiva SS; Bhargava R; Singh SV
J Natl Cancer Inst; 2013 Aug; 105(15):1111-22. PubMed ID: 23821767
[TBL] [Abstract][Full Text] [Related]
26. Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway.
McClements L; Yakkundi A; Papaspyropoulos A; Harrison H; Ablett MP; Jithesh PV; McKeen HD; Bennett R; Donley C; Kissenpfennig A; McIntosh S; McCarthy HO; O'Neill E; Clarke RB; Robson T
Clin Cancer Res; 2013 Jul; 19(14):3881-93. PubMed ID: 23741069
[TBL] [Abstract][Full Text] [Related]
27. Autophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling.
Yeo SK; Wen J; Chen S; Guan JL
Cancer Res; 2016 Jun; 76(11):3397-410. PubMed ID: 27197172
[TBL] [Abstract][Full Text] [Related]
28. Withaferin A Inhibits Fatty Acid Synthesis in Rat Mammary Tumors.
Singh KB; Hahm ER; Kim SH; Singh SV
Cancer Prev Res (Phila); 2023 Jan; 16(1):5-16. PubMed ID: 36251722
[TBL] [Abstract][Full Text] [Related]
29. Nuclear Factor Erythroid-Derived 2-Like 2-Induced Reductive Stress Favors Self-Renewal of Breast Cancer Stem-Like Cells
Kim DH; Jang JH; Kwon OS; Cha HJ; Youn HJ; Chun KS; Surh YJ
Antioxid Redox Signal; 2020 Jun; 32(18):1313-1329. PubMed ID: 31672029
[No Abstract] [Full Text] [Related]
30. Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth.
Pathania R; Ramachandran S; Mariappan G; Thakur P; Shi H; Choi JH; Manicassamy S; Kolhe R; Prasad PD; Sharma S; Lokeshwar BL; Ganapathy V; Thangaraju M
Cancer Res; 2016 Jun; 76(11):3224-35. PubMed ID: 27197203
[TBL] [Abstract][Full Text] [Related]
31. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.
Harrison H; Farnie G; Howell SJ; Rock RE; Stylianou S; Brennan KR; Bundred NJ; Clarke RB
Cancer Res; 2010 Jan; 70(2):709-18. PubMed ID: 20068161
[TBL] [Abstract][Full Text] [Related]
32. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
[TBL] [Abstract][Full Text] [Related]
33. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells.
Szarc vel Szic K; Op de Beeck K; Ratman D; Wouters A; Beck IM; Declerck K; Heyninck K; Fransen E; Bracke M; De Bosscher K; Lardon F; Van Camp G; Vanden Berghe W
PLoS One; 2014; 9(2):e87850. PubMed ID: 24498382
[TBL] [Abstract][Full Text] [Related]
35. Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.
Sehrawat A; Kim SH; Vogt A; Singh SV
Carcinogenesis; 2013 Apr; 34(4):864-73. PubMed ID: 23276794
[TBL] [Abstract][Full Text] [Related]
36. ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer.
Chen D; Bhat-Nakshatri P; Goswami C; Badve S; Nakshatri H
Cancer Res; 2013 Sep; 73(18):5821-33. PubMed ID: 23832666
[TBL] [Abstract][Full Text] [Related]
37. Withaferin A mediated changes of miRNA expression in breast cancer-derived mammospheres.
Prajapati KS; Shuaib M; Gupta S; Kumar S
Mol Carcinog; 2022 Sep; 61(9):876-889. PubMed ID: 35770722
[TBL] [Abstract][Full Text] [Related]
38. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
39. An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation.
Smit L; Berns K; Spence K; Ryder WD; Zeps N; Madiredjo M; Beijersbergen R; Bernards R; Clarke RB
Oncotarget; 2016 Jan; 7(3):2596-610. PubMed ID: 26595803
[TBL] [Abstract][Full Text] [Related]
40. Withaferin A-mediated apoptosis in breast cancer cells is associated with alterations in mitochondrial dynamics.
Sehrawat A; Samanta SK; Hahm ER; St Croix C; Watkins S; Singh SV
Mitochondrion; 2019 Jul; 47():282-293. PubMed ID: 30685490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
